Branded-generic trade names
FDA guidances on drug names will close loophole that allows generic firms that distribute the drug but do not hold the ANDA to escape FDA trade name review for branded generics. The Institute for Safe Medication Practices points out that Andrx's Procet brand of generic hydrocodone/acetaminophen, not yet marketed, is similar to Percocet (oxycodone/acetaminophen) and shares the indication for moderate to moderately severe pain. Procet did not go through review by FDA's drug name working group because the ANDA was held by Mallinckrodt
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth